This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aguero-Rosenfeld, M. E.
Right arrow Articles by Wormser, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguero-Rosenfeld, M. E.
Right arrow Articles by Wormser, G. P.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, July 2005, p. 484-509, Vol. 18, No. 3
0893-8512/05/$08.00+0     doi:10.1128/CMR.18.3.484-509.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Diagnosis of Lyme Borreliosis

Maria E. Aguero-Rosenfeld,1,4* Guiqing Wang,2 Ira Schwartz,2 and Gary P. Wormser3,4

Departments of Pathology,1 Microbiology and Immunology,2 Medicine, Division of Infectious Diseases, New York Medical College,3 Westchester Medical Center, Valhalla, New York4

A large amount of knowledge has been acquired since the original descriptions of Lyme borreliosis (LB) and of its causative agent, Borrelia burgdorferi sensu stricto. The complexity of the organism and the variations in the clinical manifestations of LB caused by the different B. burgdorferi sensu lato species were not then anticipated. Considerable improvement has been achieved in detection of B. burgdorferi sensu lato by culture, particularly of blood specimens during early stages of disease. Culturing plasma and increasing the volume of material cultured have accomplished this. Further improvements might be obtained if molecular methods are used for detection of growth in culture and if culture methods are automated. Unfortunately, culture is insensitive in extracutaneous manifestations of LB. PCR and culture have high sensitivity on skin samples of patients with EM whose diagnosis is based mostly on clinical recognition of the lesion. PCR on material obtained from extracutaneous sites is in general of low sensitivity, with the exception of synovial fluid. PCR on synovial fluid has shown a sensitivity of up to >90% (when using four different primer sets) in patients with untreated or partially treated Lyme arthritis, making it a helpful confirmatory test in these patients. Currently, the best use of PCR is for confirmation of the clinical diagnosis of suspected Lyme arthritis in patients who are IgG immunoblot positive. PCR should not be used as the sole laboratory modality to support a clinical diagnosis of extracutaneous LB. PCR positivity in seronegative patients suspected of having late manifestations of LB most likely represents a false-positive result. Because of difficulties in direct methods of detection, laboratory tests currently in use are mainly those detecting antibodies to B. burgdorferi sensu lato. Tests used to detect antibodies to B. burgdorferi sensu lato have evolved from the initial formats as more knowledge on the immunodominant antigens has been collected. The recommendation for two-tier testing was an attempt to standardize testing and improve specificity in the United States. First-tier assays using whole-cell sonicates of B. burgdorferi sensu lato need to be standardized in terms of antigen composition and detection threshold of specific immunoglobulin classes. The search for improved serologic tests has stimulated the development of recombinant protein antigens and the synthesis of specific peptides from immunodominant antigens. The use of these materials alone or in combination as the source of antigen in a single-tier immunoassay may someday replace the currently recommended two-tier testing strategy. Evaluation of these assays is currently being done, and there is evidence that certain of these antigens may be broadly cross-reactive with the B. burgdorferi sensu lato species causing LB in Europe.

* Corresponding author. Mailing address: Clinical Laboratories, Room 1J-04, Westchester Medical Center, Valhalla, NY 10595. Phone: (914) 493-7389. Fax: (914) 493-5742. E-mail: m_aguero-rosenfeld{at}nymc.edu.

Clinical Microbiology Reviews, July 2005, p. 484-509, Vol. 18, No. 3
0893-8512/05/$08.00+0     doi:10.1128/CMR.18.3.484-509.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Coleman, A. S., Pal, U. (2009). BBK07, a Dominant In Vivo Antigen of Borrelia burgdorferi, Is a Potential Marker for Serodiagnosis of Lyme Disease. CVI 16: 1569-1575 [Abstract] [Full Text]  
  • Wormser, G. P., Schwartz, I. (2009). Antibiotic Treatment of Animals Infected with Borrelia burgdorferi. Clin. Microbiol. Rev. 22: 387-395 [Abstract] [Full Text]  
  • Ogden, N. H., Lindsay, L. R., Morshed, M., Sockett, P. N., Artsob, H. (2009). The emergence of Lyme disease in Canada. CMAJ 180: 1221-1224 [Full Text]  
  • Hildenbrand, P., Craven, D.E., Jones, R., Nemeskal, P. (2009). Lyme Neuroborreliosis: Manifestations of a Rapidly Emerging Zoonosis. Am. J. Neuroradiol. 30: 1079-1087 [Abstract] [Full Text]  
  • Zygner, W., Gorski, P., Wedrychowicz, H. (2009). Detection of the DNA of Borrelia afzelii, Anaplasma phagocytophilum and Babesia canis in blood samples from dogs in Warsaw. Vet Rec. 164: 465-467 [Abstract] [Full Text]  
  • Thompson, A., Mannix, R., Bachur, R. (2009). Acute Pediatric Monoarticular Arthritis: Distinguishing Lyme Arthritis From Other Etiologies. Pediatrics 123: 959-965 [Abstract] [Full Text]  
  • Ledue, T. B., Collins, M. F., Young, J., Schriefer, M. E. (2008). Evaluation of the Recombinant VlsE-Based Liaison Chemiluminescence Immunoassay for Detection of Borrelia burgdorferi and Diagnosis of Lyme Disease. CVI 15: 1796-1804 [Abstract] [Full Text]  
  • Cerar, T., Ogrinc, K., Cimperman, J., Lotric-Furlan, S., Strle, F., Ruzic-Sabljic, E. (2008). Validation of Cultivation and PCR Methods for Diagnosis of Lyme Neuroborreliosis. J. Clin. Microbiol. 46: 3375-3379 [Abstract] [Full Text]  
  • Wormser, G. P., Nowakowski, J., Nadelman, R. B., Visintainer, P., Levin, A., Aguero-Rosenfeld, M. E. (2008). Impact of Clinical Variables on Borrelia burgdorferi-Specific Antibody Seropositivity in Acute-Phase Sera from Patients in North America with Culture-Confirmed Early Lyme Disease. CVI 15: 1519-1522 [Abstract] [Full Text]  
  • Barbour, A. G., Jasinskas, A., Kayala, M. A., Davies, D. H., Steere, A. C., Baldi, P., Felgner, P. L. (2008). A Genome-Wide Proteome Array Reveals a Limited Set of Immunogens in Natural Infections of Humans and White-Footed Mice with Borrelia burgdorferi. Infect. Immun. 76: 3374-3389 [Abstract] [Full Text]  
  • Londono, D., Marques, A., Hornung, R. L., Cadavid, D. (2008). IL-10 Helps Control Pathogen Load during High-Level Bacteremia. J. Immunol. 181: 2076-2083 [Abstract] [Full Text]  
  • Binnicker, M. J., Jespersen, D. J., Harring, J. A., Rollins, L. O., Bryant, S. C., Beito, E. M. (2008). Evaluation of Two Commercial Systems for Automated Processing, Reading, and Interpretation of Lyme Borreliosis Western Blots. J. Clin. Microbiol. 46: 2216-2221 [Abstract] [Full Text]  
  • Schollkopf, C., Melbye, M., Munksgaard, L., Smedby, K. E., Rostgaard, K., Glimelius, B., Chang, E. T., Roos, G., Hansen, M., Adami, H.-O., Hjalgrim, H. (2008). Borrelia infection and risk of non-Hodgkin lymphoma. Blood 111: 5524-5529 [Abstract] [Full Text]  
  • Eisendle, K., Grabner, T., Kutzner, H., Zelger, B. (2008). Possible Role of Borrelia burgdorferi Sensu Lato Infection in Lichen Sclerosus. Arch Dermatol 144: 591-598 [Abstract] [Full Text]  
  • White, K. P., Barry, C. I., Patterson, J. W. (2008). Focus-Floating Microscopy for Detecting Borrelia Species in Tissue Sections: Back to Basics. Arch Dermatol 144: 662-663 [Full Text]  
  • Dong, J., Olano, J. P., McBride, J. W., Walker, D. H. (2008). Emerging Pathogens: Challenges and Successes of Molecular Diagnostics. J. Mol. Diagn. 10: 185-197 [Abstract] [Full Text]  
  • Mayer, L., Merz, S., Maloney, E. L., Holmes, K. D., Volkman, D. J., Cameron, D. J., Drapkin, M. S., Feder, H. M. Jr., the Ad Hoc International Lyme Disease Group, (2008). An Appraisal of "Chronic Lyme Disease". NEJM 358: 428-431 [Full Text]  
  • Embers, M. E., Jacobs, M. B., Johnson, B. J. B., Philipp, M. T. (2007). Dominant Epitopes of the C6 Diagnostic Peptide of Borrelia burgdorferi Are Largely Inaccessible to Antibody on the Parent VlsE Molecule. CVI 14: 931-936 [Abstract] [Full Text]  
  • Tibbles, C. D., Edlow, J. A. (2007). Does This Patient Have Erythema Migrans?. JAMA 297: 2617-2627 [Abstract] [Full Text]  
  • Peterson, S. H., Nardelli, D. T., Warner, T. F., Callister, S. M., Torrealba, J. R., Schell, R. F. (2007). Anti-p19 Antibody Treatment Exacerbates Lyme Arthritis and Enhances Borreliacidal Activity. CVI 14: 510-517 [Abstract] [Full Text]  
  • Cheng, K. Y., Chang, C.-D., Salbilla, V. A., Kirchhoff, L. V., Leiby, D. A., Schochetman, G., Shah, D. O. (2007). Immunoblot Assay Using Recombinant Antigens as a Supplemental Test To Confirm the Presence of Antibodies to Trypanosoma cruzi. CVI 14: 355-361 [Abstract] [Full Text]  
  • Miller, R F, O'Connell, S, Manji, H (2006). Reinfection with Lyme borreliosis presenting as a painful polyradiculopathy: Bannwarth's, Beevor's and Borrelia.. J. Neurol. Neurosurg. Psychiatry 77: 1293-1294 [Full Text]  
  • Swanson, S. J., Neitzel, D., Reed, K. D., Belongia, E. A. (2006). Coinfections Acquired from Ixodes Ticks. Clin. Microbiol. Rev. 19: 708-727 [Abstract] [Full Text]  
  • Porwancher, R. (2006). Predictive Model for Lyme Meningitis. Pediatrics 118: 438-439 [Full Text]  
  • Wormser, G. P. (2006). Clinical practice. Early Lyme disease.. NEJM 354: 2794-2801 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»